Company Profile - X4 Pharmaceuticals Inc

Introduction

X4 Pharmaceuticals Inc, formerly Arsanis Inc, is a clinical stage bio pharmaceutical company that develops oral, small molecule therapeutics to treat cancer and rare diseases. The company’s pipeline products include Mavorixafor, an allosteric inhibitor of CXCR4 for the treatment of Warts, Hypogammaglobulinemia, Immunodeficiency and Myelokathexis (WHIM) syndrome X4P-002 and X4P-003, small molecule antagonists of chemokine receptor CXCR4 for treating glioblastoma multiforme and primary immune deficiencies (PI's). The company is developing oral allosteric antagonists of CXCR4 in order to block overstimulation of the CXCL12/CXCR4 pathway that enables trafficking of immune cells and effective immunosurveillance. X4 is headquartered in Cambridge, Massachusetts, the US..